vTv Therapeutics Inc. (VTVT) financial statements (2021 and earlier)
Company profile
| Business Address |
3980 PREMIER DR HIGH POINT, NC 27265 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 2 | 2 | 12 | 52 | 88 | ||
| Cash and cash equivalents | 2 | 2 | 12 | 52 | 88 | ||
| Restricted cash and investments | 0 | ||||||
| Receivables | 0 | 8 | 0 | ||||
| Prepaid expense | 1 | 1 | |||||
| Deposits current assets | 0 | 1 | |||||
| Other undisclosed current assets | 0 | 1 | 1 | ||||
| Total current assets: | 3 | 3 | 20 | 52 | 89 | ||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 1 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 0 | 0 | 0 | 0 | 1 | ||
| Long-term investments and receivables | 2 | 2 | 2 | 0 | |||
| Long-term investments | 2 | 2 | 2 | ||||
| Due from related parties | 0 | ||||||
| Deposits noncurrent assets | 0 | 0 | 2 | ||||
| Restricted cash and investments | 3 | 3 | 3 | ||||
| Other noncurrent assets | 2 | 2 | |||||
| Total noncurrent assets: | 6 | 5 | 8 | 2 | 2 | ||
| TOTAL ASSETS: | 9 | 9 | 28 | 54 | 92 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 7 | 8 | 14 | 11 | 7 | ||
| Accounts payable | 2 | 3 | 2 | 3 | 3 | ||
| Accrued liabilities | 0 | 0 | 1 | 1 | 0 | ||
| Employee-related liabilities | 1 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 5 | 5 | 10 | 8 | 2 | ||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 6 | 9 | 4 | ||||
| Due to related parties | 1 | ||||||
| Deferred revenue and credits | ✕ | ✕ | 9 | 0 | 0 | ||
| Contract with customer, liability | ✕ | 2 | ✕ | ✕ | ✕ | ||
| Total current liabilities: | 13 | 19 | 27 | 11 | 8 | ||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 1 | 6 | 15 | 11 | |||
| Long-term debt, excluding current maturities | 6 | 15 | 11 | ||||
| Operating lease, liability | 1 | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 4 | 4 | 5 | 0 | 0 | ||
| Deferred revenue and credits | ✕ | ✕ | 4 | ||||
| Deferred revenue | 1 | ✕ | ✕ | ✕ | ✕ | ||
| Contract with customer, liability | ✕ | 1 | ✕ | ✕ | ✕ | ||
| Asset retirement obligations | 0 | ||||||
| Due to related parties | 3 | 2 | 0 | ||||
| Other liabilities | 0 | 0 | 0 | 0 | |||
| Other undisclosed noncurrent liabilities | 0 | ||||||
| Total noncurrent liabilities: | 5 | 10 | 21 | 11 | 0 | ||
| Total liabilities: | 18 | 29 | 48 | 23 | 8 | ||
| Temporary equity, carrying amount | 40 | 62 | 131 | 123 | 162 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (49) | (83) | (151) | (91) | (78) | ||
| Additional paid in capital | 184 | 151 | 128 | 124 | 118 | ||
| Accumulated deficit | (234) | (234) | (279) | (215) | (196) | ||
| Other undisclosed stockholders' equity attributable to parent | 1 | 0 | 0 | 0 | 0 | ||
| Total stockholders' equity: | (49) | (83) | (151) | (91) | (78) | ||
| TOTAL LIABILITIES AND EQUITY: | 9 | 9 | 28 | 54 | 92 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Revenue, net | ✕ | ✕ | 0 | 1 | 1 | |
| Gross profit: | 3 | 12 | 0 | 1 | 1 | |
| Operating expenses | (24) | (32) | (51) | (56) | (39) | |
| Operating loss: | (21) | (20) | (51) | (55) | (38) | |
| Nonoperating income (expense) | 0 | 0 | 0 | 0 | (1) | |
| Investment income, nonoperating | 0 | 0 | 0 | 0 | ||
| Other nonoperating income (expense) | 0 | 0 | (0) | (1) | ||
| Interest and debt expense | (2) | (3) | (3) | (0) | (0) | |
| Loss from continuing operations before equity method investments, income taxes: | (23) | (23) | (54) | (55) | (39) | |
| Other undisclosed income (loss) from continuing operations before income taxes | 1 | (1) | (0) | (2) | ||
| Loss from continuing operations before income taxes: | (22) | (24) | (54) | (55) | (41) | |
| Income tax expense | (0) | (0) | (1) | |||
| Net loss: | (22) | (24) | (55) | (55) | (41) | |
| Net income attributable to noncontrolling interest | 9 | 16 | 39 | 39 | 14 | |
| Net loss attributable to parent: | (13) | (8) | (16) | (16) | (27) | |
| Other undisclosed net loss available to common stockholders, basic | (5) | (1) | ||||
| Net loss available to common stockholders, diluted: | (18) | (9) | (16) | (16) | (27) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Net loss: | (22) | (24) | (55) | (55) | (41) | |
| Comprehensive loss: | (22) | (24) | (55) | (55) | (41) | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 9 | 16 | 39 | 39 | 14 | |
| Comprehensive loss, net of tax, attributable to parent: | (13) | (8) | (16) | (16) | (27) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.